African states are particularly at risk as they import 70% of their pharmaceutical products. The continent is main hub for the trade in counterfeit medicines, as organised criminals seek to exploit fragile states to import, manufacture, traffic and sell falsified medicines.
Antimalarials and antibiotics are among the most commonly reported fake products. The average global antimalarial failure rate is 47%.